Cargando…

Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications

High density lipoproteins (HDLs) are commonly known for their anti-atherogenic properties that include functions such as the promotion of cholesterol efflux and reverse cholesterol transport, as well as antioxidant and anti-inflammatory activities. However, because of some chronic inflammatory disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonilha, Isabella, Zimetti, Francesca, Zanotti, Ilaria, Papotti, Bianca, Sposito, Andrei C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196572/ https://www.ncbi.nlm.nih.gov/pubmed/34063950 http://dx.doi.org/10.3390/jcm10112233

Ejemplares similares

High-Density Lipoproteins in Non-Cardiovascular Diseases
por: Zanotti, Ilaria
Publicado: (2022)

Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis
por: Kocyigit, Duygu, et al.
Publicado: (2021)

The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus
por: Bonilha, Isabella, et al.
Publicado: (2021)

High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
por: Adorni, Maria Pia, et al.
Publicado: (2021)

Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial
por: Breder, Ikaro, et al.
Publicado: (2020)

Very low HDL levels: clinical assessment and management
por: Bonilha, Isabella, et al.
Publicado: (2023)

Polyphenol Health Effects on Cardiovascular and Neurodegenerative Disorders: A Review and Meta-Analysis
por: Potì, Francesco, et al.
Publicado: (2019)

High Density Lipoprotein and it’s Dysfunction
por: Eren, Esin, et al.
Publicado: (2012)

Low-density lipoprotein cholesterol and radiotherapy-induced carotid atherosclerosis in subjects with head and neck cancer
por: Pereira, Eduardo B, et al.
Publicado: (2014)

HDL Proteome and Alzheimer’s Disease: Evidence of a Link
por: Marsillach, Judit, et al.
Publicado: (2020)

High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
por: Androulakis, Emmanuel, et al.
Publicado: (2017)

Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19
por: Carmo, Helison Rafael P., et al.
Publicado: (2023)

Editorial: Beyond Cardiovascular Disease: Challenging New Pathways in Lipid and Lipoprotein Metabolism
por: Passarelli, Marisa, et al.
Publicado: (2022)

PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer’s Disease
por: Papotti, Bianca, et al.
Publicado: (2022)

High-Density Lipoprotein Function and Dysfunction in Health and Disease
por: Chiesa, Scott T., et al.
Publicado: (2019)

High -density lipoprotein cholesterol as a predictor for diabetes mellitus
por: Wu, Hong, et al.
Publicado: (2018)

Impact of Dietary Lipids on the Reverse Cholesterol Transport: What We Learned from Animal Studies
por: Papotti, Bianca, et al.
Publicado: (2021)

Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics
por: Salazar, Juan, et al.
Publicado: (2015)

Anticipatory Role of High Density Lipoprotein and Endothelial Dysfunction: An Overview
por: Eren, Esin, et al.
Publicado: (2014)

Dysfunctional high-density lipoprotein in chronic inflammatory rheumatic diseases
por: Waldecker-Gall, Sabina, et al.
Publicado: (2023)

Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion
por: Zanotti, Ilaria, et al.
Publicado: (2013)

Small Dense Low-Density Lipoprotein Level in Newly Diagnosed Type 2 Diabetes Mellitus Patients With Normal Low-Density Lipoprotein
por: Juhi, Ayesha, et al.
Publicado: (2023)

High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential
por: Jomard, Anne, et al.
Publicado: (2020)

Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential
por: Di, Lin, et al.
Publicado: (2021)

The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes
por: Kashyap, Sangeeta, et al.
Publicado: (2016)

The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid
por: Rio, Daniele Del, et al.
Publicado: (2017)

High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells
por: Hafiane, Anouar, et al.
Publicado: (2022)

Effect of the JAK/STAT Inhibitor Tofacitinib on Macrophage Cholesterol Metabolism
por: Adorni, Maria Pia, et al.
Publicado: (2023)

Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure
por: Tsigkou, Vasiliki, et al.
Publicado: (2023)

Dysfunctional high-density lipoprotein: not only quantity but first of all quality?
por: Agouridis, Aris P., et al.
Publicado: (2015)

Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction
por: Abdo, Adrian I., et al.
Publicado: (2017)

Oxidized Low-Density Lipoprotein Drives Dysfunction of the Liver Lymphatic System
por: Burchill, Matthew A., et al.
Publicado: (2020)

The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus
por: Hu, Xiangming, et al.
Publicado: (2022)

Erratum to: The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes
por: Kashyap, Sangeeta, et al.
Publicado: (2016)

Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers
por: Gramantieri, Laura, et al.
Publicado: (2021)

Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritis
por: Karpouzas, George Athanasios, et al.
Publicado: (2022)

Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease
por: Besler, Christian, et al.
Publicado: (2012)

Anti-High-Density Lipoprotein Antibodies and Antioxidant Dysfunction in Immune-Driven Diseases
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2018)

Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion
por: Chen, Zhongli, et al.
Publicado: (2020)

Association between measured or calculated small dense low‐density lipoprotein cholesterol and oxidized low‐density lipoprotein in subjects with or without type 2 diabetes mellitus
por: Kim, Hyun‐Ki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fg9nlp572r6p9snm1utv93vupj